SALT LAKE CITY--(BUSINESS WIRE)--Recursion announces a research agreement with Sanofi Genzyme to deploy its drug repurposing platform to identify new uses for Sanofi’s clinical stage molecules across dozens of genetic diseases.
![]()
↧